DYRK1A (Q13627) variants and mutations
DYRK1A (also known as Q13627) is a human protein-coding gene encoding a dual specificity tyrosine-phosphorylation-regulated kinase 1A protein. It phosphorylates numerous transcriptional, synaptic, and cell-cycle targets during brain development and is highly dosage sensitive. Haploinsufficiency causes DYRK1A syndrome, typically with microcephaly, developmental delay, intellectual disability, and frequent seizures or autism-related features. This analysis covers 1,224 DYRK1A variants and mutations. Of these, 55% have computational variant effect predictions. Disease context includes DYRK1A-related intellectual disability syndrome, complex neurodevelopmental disorder, and microcephaly. Example DYRK1A variants include H2L, T3A, and T3I.
Variant analysis overview
- Gene: DYRK1A
- Protein: Q13627
- UniProt accession: Q13627
- Organism: Homo sapiens
- Variants analyzed: 1224
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 1,079 unspecified-consequence records; 85 missense variants; 49 synonymous variants; 4 splice-region variants; 5 frameshift variants; 1 in-frame deletions; 1 substitution
- Prediction scores: 678 variants have prediction scores (55% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: DYRK1A-related intellectual disability syndrome, complex neurodevelopmental disorder, microcephaly, Intellectual disability, hereditary disease, Rare genetic intellectual disability with developmental anomaly, Seizure, absent or delayed speech development, Deeply set eye, Feeding difficulties, Global developmental delay, autism spectrum disorder.
Protein structure and variant hotspots
- Protein features: 1 domains; 3 binding sites; 16 post-translational modification sites.
- Structural context: 417 variants have structural context.
- PTM context: 23 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable DYRK1A variants
Examples include H2L, T3A, T3I, T3K, T3T, G4*, G4E, G5*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- H2L (p.His2Leu), ExAC rs747540667, gnomAD rs747540667, MetaLR 0.19, MetaSVM -0.72
- T3A (p.Thr3Ala), rs2148427299, ClinGen CA409967804, ClinVar RCV002136835, Ensembl rs2148427299, AlphaMissense 0.07, MetaLR 0.15, Benign
- T3I (p.Thr3Ile), rs2051633743, gnomAD 21-37456285-C-T, CADD 1.21, SIFT 0.09
- T3K (p.Thr3Lys), gnomAD 21-37456285-C-A, CADD 0.76, SIFT 0.68
- T3T (p.Thr3Thr), gnomAD 21-37456289-A-G, CADD 0.24
- G4* (p.Gly4Ter), Ensembl rs1555960035
- G4E (p.Gly4Glu), NCI-TCGA Cosmic COSV5829, cosmic curated COSV58297, MetaLR 0.37, MetaSVM -0.49, Variant assessed as somatic; moderate impact.
- G5* (p.Gly5Ter), Ensembl rs1555976928
- G5R (p.Gly5Arg), cosmic curated COSV10520, MetaLR 0.38, MetaSVM -0.30
- G5C (p.Gly5Cys), gnomAD 21-37456302-G-T, CADD 0.52, SIFT 0.02
- G5S (p.Gly5Ser), rs2051634221, gnomAD 21-37456302-G-A, CADD 0.76, SIFT 0.33
- G5D (p.Gly5Asp), gnomAD 21-37456303-G-A, CADD 3.04, SIFT 0.02
- G5V (p.Gly5Val), gnomAD 21-37456306-G-T, CADD 5.52, SIFT 0.07
- G5E (p.Gly5Glu), gnomAD 21-37456306-G-A, CADD 2.46, SIFT 0.05
- G5G (p.Gly5Gly), gnomAD 21-37456307-A-G, CADD 9.01
- E6* (p.Glu6Ter), ExAC rs757452222, gnomAD rs757452222
- E6K (p.Glu6Lys), ExAC rs757452222, gnomAD rs757452222, CADD 2.43, SIFT 0.03
- E6G (p.Glu6Gly), gnomAD 21-37456294-A-G, CADD 2.92, SIFT 0.01
- T7A (p.Thr7Ala), rs2052265794, ClinGen CA409942077, ClinVar RCV001232564, ClinVar RCV001564383, MetaLR 0.32, MetaSVM -0.45, Likely benign
- T7N (p.Thr7Asn), gnomAD 21-37472693-C-A, MetaLR 0.34, MetaSVM -0.46
- S8* (p.Ser8Ter), cosmic curated COSV10463, CADD 38.00
- S8L (p.Ser8Leu), NCI-TCGA TCGA novel, MetaLR 0.33, MetaSVM -0.48, Variant assessed as somatic; moderate impact.
- S8A (p.Ser8Ala), gnomAD 21-37472695-T-G, MetaLR 0.29, MetaSVM -0.52
- S8P (p.Ser8Pro), gnomAD 21-37472695-T-C, MetaLR 0.32, MetaSVM -0.44
- S8S (p.Ser8Ser), rs1163518085, gnomAD 21-37472697-A-G, CADD 13.50
- A9T (p.Ala9Thr), NCI-TCGA TCGA novel, MetaLR 0.34, MetaSVM -0.46, Variant assessed as somatic; moderate impact.
- A9S (p.Ala9Ser), gnomAD 21-37456296-G-T, CADD 3.91, SIFT 0.30
- A9D (p.Ala9Asp), gnomAD 21-37456297-C-A, CADD 1.22, SIFT 0.06
- A9A (p.Ala9Ala), gnomAD 21-37456298-T-C, CADD 3.92
- A9P (p.Ala9Pro), gnomAD 21-37456299-G-C, CADD 0.38, SIFT 0.03
- A9V (p.Ala9Val), gnomAD 21-37456300-C-T, CADD 4.62, SIFT 0.18
- A9E (p.Ala9Glu), gnomAD 21-37456300-C-A, CADD 2.35, SIFT 0.01
- C10* (p.Cys10Ter), rs1555976936, Ensembl rs1555976936, CADD 38.00, Variant assessed as somatic; high impact.
- C10R (p.Cys10Arg), gnomAD 21-37472701-T-C, MetaLR 0.36, MetaSVM -0.32
- C10Y (p.Cys10Tyr), gnomAD 21-37472702-G-A, MetaLR 0.39, MetaSVM -0.35
- K11* (p.Lys11Ter), Ensembl rs1555976941
- K11R (p.Lys11Arg), gnomAD 21-37472705-A-G, MetaLR 0.32, MetaSVM -0.45
- K11T (p.Lys11Thr), gnomAD 21-37472705-A-C, MetaLR 0.32, MetaSVM -0.44
- P12S (p.Pro12Ser), ExAC rs778892348, gnomAD rs778892348, MetaLR 0.22, MetaSVM -0.71
- P12L (p.Pro12Leu), gnomAD 21-37472708-C-T, MetaLR 0.17, MetaSVM -0.87
- P12P (p.Pro12Pro), gnomAD 21-37472709-T-C, CADD 14.40
- S13L (p.Ser13Leu), cosmic curated COSV10520, MetaLR 0.32, MetaSVM -0.44
- S13S (p.Ser13Ser), rs745895020, gnomAD 21-37472712-A-C, CADD 12.90
- S14P (p.Ser14Pro), ExAC rs771919737, gnomAD rs771919737, MetaLR 0.36, MetaSVM -0.33
- S14Y (p.Ser14Tyr), gnomAD 21-37472714-C-A, MetaLR 0.39, MetaSVM -0.35
- V15F (p.Val15Phe), ExAC rs780200883, TOPMed rs780200883, gnomAD rs780200883, MetaLR 0.34, MetaSVM -0.47, Benign
- V15I (p.Val15Ile), rs780200883, ClinGen CA10023699, ClinVar RCV001205973, ClinVar RCV005550169, MetaLR 0.32, MetaSVM -0.59, Benign
- R16L (p.Arg16Leu), TOPMed rs1057175147, gnomAD rs1057175147, MetaLR 0.16, MetaSVM -0.80, Benign
- R16Q (p.Arg16Gln), rs1057175147, ClinGen CA409942215, ClinVar RCV000536161, ClinVar RCV006264067, MetaLR 0.17, MetaSVM -0.88, Benign
- R16W (p.Arg16Trp), rs1409541555, ClinGen CA409942213, NCI-TCGA Cosmic COSV5829, cosmic curated COSV58292, MetaLR 0.28, MetaSVM -0.59, Uncertain significance
- R16K (p.Arg16Lys), gnomAD 21-37456282-G-A, CADD 0.37, SIFT 1.00
- R16R (p.Arg16Arg), gnomAD 21-37456283-A-G, CADD 3.75
- L17R (p.Leu17Arg), ExAC rs768615289, gnomAD rs768615289, MetaLR 0.36, MetaSVM -0.35
- L17I (p.Leu17Ile), gnomAD 21-37472722-C-A, MetaLR 0.33, MetaSVM -0.60
- A18E (p.Ala18Glu), NCI-TCGA Cosmic COSV1001, MetaLR 0.34, MetaSVM -0.46, Variant assessed as somatic; moderate impact.
- A18V (p.Ala18Val), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10011, MetaLR 0.34, MetaSVM -0.47, Variant assessed as somatic; moderate impact.
- A18T (p.Ala18Thr), gnomAD 21-37472725-G-A, MetaLR 0.34, MetaSVM -0.47
- A18S (p.Ala18Ser), gnomAD 21-37472725-G-T, MetaLR 0.34, MetaSVM -0.49
- P19L (p.Pro19Leu), rs1056885794, ClinGen CA320471805, cosmic curated COSV58296, ClinVar RCV001924798, MetaLR 0.34, MetaSVM -0.46, Uncertain significance
- P19S (p.Pro19Ser), ExAC rs776541736, gnomAD rs776541736, MetaLR 0.34, MetaSVM -0.47
- P19P (p.Pro19Pro), rs747774015, gnomAD 21-37472730-G-A, CADD 12.30
- S20A (p.Ser20Ala), gnomAD 21-37472731-T-G, MetaLR 0.25, MetaSVM -0.64
- S20S (p.Ser20Ser), rs1049754, gnomAD 21-37472733-A-G, CADD 9.92
- F21C (p.Phe21Cys), Ensembl rs2148556418, MetaLR 0.21, MetaSVM -0.68
- F21L (p.Phe21Leu), gnomAD 21-37472734-T-C, MetaLR 0.11, MetaSVM -1.03
- S22L (p.Ser22Leu), cosmic curated COSV10735, MetaLR 0.32, MetaSVM -0.46
- S22H (p.Ser22His), gnomAD 21-37472733-AT-A, CADD 26.80
- S22S (p.Ser22Ser), rs1178275452, gnomAD 21-37472739-A-G, CADD 13.70
- F23L (p.Phe23Leu), rs2517957532, ClinGen CA409942311, ClinVar RCV003225518, Uncertain significance
- H24H (p.His24His), gnomAD 21-37472745-T-C, CADD 12.00
- A25T (p.Ala25Thr), gnomAD 21-37472746-G-A, MetaLR 0.13, MetaSVM -1.04
- A25A (p.Ala25Ala), rs536947921, gnomAD 21-37472748-T-G, CADD 14.10
- A26T (p.Ala26Thr), rs2148556430, ClinGen CA409942344, ClinVar RCV002019009, Ensembl rs2148556430, MetaLR 0.34, MetaSVM -0.47, Uncertain significance, DYRK1A-related intellectual disability syndrome
- G27S (p.Gly27Ser), ExAC rs769445831, gnomAD rs769445831, MetaLR 0.33, MetaSVM -0.63
- G27G (p.Gly27Gly), rs1224053638, gnomAD 21-37472754-C-T, CADD 12.70
- L28F (p.Leu28Phe), cosmic curated COSV58292, MetaLR 0.23, MetaSVM -0.78
- Q29* (p.Gln29Ter), ExAC rs772599209, gnomAD rs772599209
- Q29E (p.Gln29Glu), ExAC rs772599209, gnomAD rs772599209, MetaLR 0.17, MetaSVM -0.91
- Q29H (p.Gln29His), rs1010198969, ClinGen CA409942390, ClinVar RCV001986591, TOPMed rs1010198969, AlphaMissense 0.18, MetaLR 0.24, Uncertain significance
- Q29K (p.Gln29Lys), gnomAD 21-37456290-C-A, CADD 1.25, SIFT 0.03
- Q29R (p.Gln29Arg), rs2051633942, gnomAD 21-37456291-A-G, CADD 0.63, SIFT 0.01
- Q29Q (p.Gln29Gln), rs1010198969, gnomAD 21-37472760-G-A, AlphaMissense 0.18, MetaLR 0.24
- M30I (p.Met30Ile), cosmic curated COSV58292
- M30L (p.Met30Leu), rs762466544, ClinGen CA409942397, ClinVar RCV003641887, ExAC rs762466544, AlphaMissense 0.11, MetaLR 0.19, Benign
- M30V (p.Met30Val), rs762466544, ClinGen CA10023706, ClinVar RCV000931147, ExAC rs762466544, AlphaMissense 0.11, MetaLR 0.19, Benign
- A31T (p.Ala31Thr), rs765791729, ClinGen CA10023707, ClinVar RCV003641507, ExAC rs765791729, MetaLR 0.28, MetaSVM -0.64, Uncertain significance, DYRK1A-related intellectual disability syndrome
- A31A (p.Ala31Ala), rs776043893, gnomAD 21-37472766-T-C, CADD 14.30
- G32* (p.Gly32Ter), gnomAD rs1447082182
- G32A (p.Gly32Ala), Ensembl rs1049756, MetaLR 0.06, MetaSVM -1.04
- G32R (p.Gly32Arg), gnomAD rs1447082182, MetaLR 0.18, MetaSVM -0.84
- G32V (p.Gly32Val), rs1049756, ClinGen CA409942430, ClinVar RCV003067018, MetaLR 0.11, MetaSVM -0.91, Uncertain significance
- G32G (p.Gly32Gly), gnomAD 21-37472769-A-T, CADD 13.80
- Q33* (p.Gln33Ter), Ensembl rs1555977020
- Q33R (p.Gln33Arg), TOPMed rs1316698572, MetaLR 0.12, MetaSVM -0.95
- Q33E (p.Gln33Glu), gnomAD 21-37472770-C-G, MetaLR 0.15, MetaSVM -0.98
- M34V (p.Met34Val), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10011, MetaLR 0.18, MetaSVM -0.83, Variant assessed as somatic; moderate impact.
- P35L (p.Pro35Leu), cosmic curated COSV10735, gnomAD rs1471802278, MetaLR 0.17, MetaSVM -0.91
- P35S (p.Pro35Ser), rs968549141, ClinGen CA320471869, ClinVar RCV000502739, TOPMed rs968549141, MetaLR 0.10, MetaSVM -1.03, Uncertain significance
- P35T (p.Pro35Thr), TOPMed rs968549141, gnomAD rs968549141, MetaLR 0.12, MetaSVM -0.96, Uncertain significance
- P35P (p.Pro35Pro), rs764466157, gnomAD 21-37472778-C-T, CADD 13.00
- H36R (p.His36Arg), NCI-TCGA Cosmic COSV5829, cosmic curated COSV58297, MetaLR 0.24, MetaSVM -0.82, Variant assessed as somatic; moderate impact.
- S37L (p.Ser37Leu), TOPMed rs2052269774, MetaLR 0.13, MetaSVM -1.01
- H38Y (p.His38Tyr), TOPMed rs2052269865, MetaLR 0.28, MetaSVM -0.68
- Q39* (p.Gln39Ter), cosmic curated COSV10641, Ensembl rs1555977035
- Q39E (p.Gln39Glu), cosmic curated COSV10735
- Q39H (p.Gln39His), rs2148556605, ClinGen CA409942531, ClinVar RCV001758760, Ensembl rs2148556605, AlphaMissense 0.10, MetaLR 0.15, Uncertain significance
- Q39Q (p.Gln39Gln), gnomAD 21-37472790-G-A, CADD 8.14
- S41G (p.Ser41Gly), rs2052270177, ClinGen CA409942541, ClinVar RCV001267544, Ensembl rs2052270177, AlphaMissense 0.08, MetaLR 0.27, Uncertain significance
- S41N (p.Ser41Asn), rs754161665, ExAC rs754161665, gnomAD rs754161665, MetaLR 0.29, MetaSVM -0.64, Uncertain significance
- S41T (p.Ser41Thr), rs754161665, ClinGen CA10023712, ClinVar RCV003819233, ExAC rs754161665, MetaLR 0.29, MetaSVM -0.67, Uncertain significance
- D42E (p.Asp42Glu), TOPMed rs1424978793, gnomAD rs1424978793
- D42T (p.Asp42Thr), NCI-TCGA TCGA novel, MetaLR 0.17, MetaSVM -0.88, Variant assessed as somatic; high impact.
- D42D (p.Asp42Asp), rs1424978793, gnomAD 21-37472799-C-T, CADD 11.20
- R43C (p.Arg43Cys), rs367984873, ClinGen CA10023713, cosmic curated COSV10885, ClinVar RCV000814785, MetaLR 0.09, MetaSVM -1.05, Benign
- R43H (p.Arg43His), rs750600368, ClinGen CA10023714, NCI-TCGA Cosmic COSV1001, cosmic curated COSV10011, AlphaMissense 0.08, MetaLR 0.12, Benign
- R43P (p.Arg43Pro), rs750600368, ClinGen CA409942556, ClinVar RCV003528613, AlphaMissense 0.08, MetaLR 0.12, Uncertain significance
- R43S (p.Arg43Ser), rs367984873, ClinGen CA409942554, ClinVar RCV001899475, NCI-TCGA TCGA novel, MetaLR 0.09, MetaSVM -1.04, Benign
- R43R (p.Arg43Arg), rs1429965771, gnomAD 21-37472802-T-C, CADD 13.50
- R44C (p.Arg44Cys), ExAC rs758573762, gnomAD rs758573762, MetaLR 0.15, MetaSVM -0.80
- R44H (p.Arg44His), rs780254690, ClinGen CA10023716, NCI-TCGA Cosmic COSV5829, ClinVar RCV002385653, MetaLR 0.06, MetaSVM -1.00, Likely benign
- R44L (p.Arg44Leu), cosmic curated COSV58297, MetaLR 0.11, MetaSVM -0.97
- Q45* (p.Gln45Ter), Ensembl rs1555977056
- Q45L (p.Gln45Leu), rs2052271309, ClinGen CA409942567, ClinVar RCV003529373, TOPMed rs2052271309, AlphaMissense 0.10, MetaLR 0.26, Benign
- Q45P (p.Gln45Pro), gnomAD 21-37472807-A-C, MetaLR 0.21, MetaSVM -0.72
- P46S (p.Pro46Ser), gnomAD 21-37472809-C-T, MetaLR 0.12, MetaSVM -1.04
- P46P (p.Pro46Pro), rs1049759, gnomAD 21-37472811-A-G, CADD 12.00
- N47D (p.Asn47Asp), rs1569354907, ClinGen CA409942577, ClinVar RCV000705630, Ensembl rs1569354907, MetaLR 0.10, MetaSVM -1.04, Uncertain significance
- N47S (p.Asn47Ser), Ensembl rs1049760, MetaLR 0.06, MetaSVM -1.08
- I48L (p.Ile48Leu), gnomAD rs1284054066, MetaLR 0.08, MetaSVM -1.07
- I48T (p.Ile48Thr), TOPMed rs1303278052, MetaLR 0.10, MetaSVM -1.02
- I48I (p.Ile48Ile), rs2052272230, gnomAD 21-37472817-A-C, CADD 11.60
- S49R (p.Ser49Arg), gnomAD 21-37472820-T-G, MetaLR 0.09, MetaSVM -1.02
- D50G (p.Asp50Gly), gnomAD 21-37472822-A-G, MetaLR 0.27, MetaSVM -0.70
- D50D (p.Asp50Asp), rs1380000716, gnomAD 21-37472823-C-T, CADD 10.40
- D50E (p.Asp50Glu), gnomAD 21-37472823-C-A, MetaLR 0.28, MetaSVM -0.78
- Q51* (p.Gln51Ter), rs1555977077, ClinGen CA409942608, ClinVar RCV000760626, Ensembl rs1555977077, AlphaMissense 0.09, MetaLR 0.22, Pathogenic
- Q51E (p.Gln51Glu), Ensembl rs1555977077, MetaLR 0.22, MetaSVM -0.91, Pathogenic
- Q51R (p.Gln51Arg), gnomAD 21-37472825-A-G, MetaLR 0.25, MetaSVM -0.81
- Q51Q (p.Gln51Gln), rs1049761, gnomAD 21-37472826-A-G, CADD 8.09
- Q52* (p.Gln52Ter), gnomAD rs1555977083, Uncertain significance
- Q52E (p.Gln52Glu), rs1555977083, ClinGen CA409942615, ClinVar RCV001355234, ClinVar RCV001871927, MetaLR 0.12, MetaSVM -1.04, Benign
- Q52Q (p.Gln52Gln), rs1248202604, gnomAD 21-37472829-G-A, CADD 9.55
- V53F (p.Val53Phe), gnomAD 21-37472830-G-T, MetaLR 0.13, MetaSVM -1.02
- V53L (p.Val53Leu), gnomAD 21-37472830-G-C, MetaLR 0.12, MetaSVM -0.99
- V53V (p.Val53Val), gnomAD 21-37472832-T-C, CADD 10.50
- S54C (p.Ser54Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S54F (p.Ser54Phe), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10011, Variant assessed as somatic; moderate impact.
- S54S (p.Ser54Ser), gnomAD 21-37472835-T-G, CADD 13.20
- A55V (p.Ala55Val), gnomAD 21-37472837-C-T, MetaLR 0.12, MetaSVM -1.05
- L56F (p.Leu56Phe), cosmic curated COSV58294
- L56L (p.Leu56Leu), gnomAD 21-37472839-T-C, CADD 12.30
- S57* (p.Ser57Ter), cosmic curated COSV58294
- S57P (p.Ser57Pro), rs1049763, ClinGen CA10023719, ClinVar RCV000806873, ClinVar RCV005328401, MetaLR 0.03, MetaSVM -1.02, Likely benign
- S57T (p.Ser57Thr), ExAC rs1049763, TOPMed rs1049763, gnomAD rs1049763, Likely benign
- S57del (p.Ser57del), gnomAD 21-37472840-TATC-, CADD 19.10
- S57S (p.Ser57Ser), rs747907599, gnomAD 21-37472844-A-G, CADD 6.57
- Y58C (p.Tyr58Cys), rs1041691170, ClinGen CA320471990, ClinVar RCV001208618, ClinVar RCV002402612, MetaLR 0.29, MetaSVM -0.62, Benign
- S59Y (p.Ser59Tyr), gnomAD 21-37472849-C-A, MetaLR 0.14, MetaSVM -0.90
- S59S (p.Ser59Ser), gnomAD 21-37472850-T-G, CADD 12.90
- D60H (p.Asp60His), TOPMed rs2052273693, MetaLR 0.27, MetaSVM -0.68
- D60Y (p.Asp60Tyr), gnomAD 21-37472851-G-T, MetaLR 0.28, MetaSVM -0.64
- D60E (p.Asp60Glu), gnomAD 21-37472853-C-A, MetaLR 0.20, MetaSVM -0.94
- D60D (p.Asp60Asp), gnomAD 21-37472853-C-T, CADD 11.30
- Q61* (p.Gln61Ter), Ensembl rs1555977119
- Q61H (p.Gln61His), NCI-TCGA Cosmic COSV5829, cosmic curated COSV58295, MetaLR 0.29, MetaSVM -0.66, Variant assessed as somatic; moderate impact.
- Q61K (p.Gln61Lys), gnomAD 21-37472854-C-A, MetaLR 0.14, MetaSVM -0.96
- Q61R (p.Gln61Arg), gnomAD 21-37472855-A-G, MetaLR 0.13, MetaSVM -1.00
- I62L (p.Ile62Leu), gnomAD 21-37472857-A-C, MetaLR 0.10, MetaSVM -1.02
- I62F (p.Ile62Phe), gnomAD 21-37472857-A-T, MetaLR 0.09, MetaSVM -1.02
- I62T (p.Ile62Thr), gnomAD 21-37472858-T-C, MetaLR 0.08, MetaSVM -1.03
- I62I (p.Ile62Ile), rs1367385854, gnomAD 21-37472859-T-C, CADD 10.80
- Q63* (p.Gln63Ter), rs373178770, ClinGen CA409942688, ClinVar RCV000520960, ClinVar RCV002250650, CADD 37.00, Pathogenic
- Q63E (p.Gln63Glu), rs373178770, ClinGen CA409942689, ClinVar RCV000523249, ClinVar RCV001857986, MetaLR 0.13, MetaSVM -1.03, Pathogenic
- Q63K (p.Gln63Lys), rs373178770, ClinGen CA10023722, ClinVar RCV003852428, ESP rs373178770, MetaLR 0.12, MetaSVM -1.03, Pathogenic
- Q63R (p.Gln63Arg), gnomAD 21-37472861-A-G, MetaLR 0.13, MetaSVM -0.97
- Q63Q (p.Gln63Gln), rs748888299, gnomAD 21-37472862-G-A, CADD 6.81
- Q64* (p.Gln64Ter), Ensembl rs1555977135, CADD 38.00
- Q64K (p.Gln64Lys), gnomAD 21-37472863-C-A, MetaLR 0.12, MetaSVM -0.97
- Q64R (p.Gln64Arg), gnomAD 21-37472864-A-G, MetaLR 0.10, MetaSVM -1.01
- Q64P (p.Gln64Pro), gnomAD 21-37472864-A-C, MetaLR 0.11, MetaSVM -0.99
Public DYRK1A analysis runs
- DYRK1A analysis run — DYRK1A (1,224 variants) — completed 2026-08-18